- 2017
- What's on? - 07.03.2017
8 March 2017: medical research conjugated in the feminine
Wednesday 8 March 2017 is devoted to International Women’s Day. In 2014, Inserm established a think-tank on “Gender and Health Research” within the Inserm Ethics Committee. Led by Catherine Vidal and Jennifer Merchant, members of the Inserm Ethics Committee, its objectives are to raise awareness about the impact of gender on health research, and to […]
- Press releases - 03.03.2017
Inserm in the world Top 10 most innovative public bodies, up one place compared to last year.
L’Inserm se classe 9e dans le « Top 25 Global Innovators – Government » Reuters/Clarivate, qui évalue la capacité d’innovation des organisations publiques en fonction de l’impact de leur production scientifique et de leurs brevets.
- Press releases - 02.03.2017
Breast cancer: identification of a molecular switch that controls cancer stem cells
Some cancer cells are resistant to treatment and persist. If they are capable of proliferating again, even a very small number of these cells may be enough to reconstitute a tumour after or despite treatment. Various approaches to eliminate these “cancer stem cells” (CSCs) have been tried in recent years: targeted therapies, vaccination and tumour starvation. In an article published in the journal Cell Reports, Christophe Ginestier, Inserm Research Fellow at the Cancer Research Center of Marseille (CRCM, Aix-Marseille University/CNRS/Institut Paoli-Calmettes), and his collaborators identify a specific RNA[1] molecule that plays the role of a molecular switch that can “turn off” or “turn on” CSC proliferation in breast cancers.
- Press releases - 01.03.2017
1 March 2017: A plan for action on violence against children
Wednesday 1 March 2017 will see the unveiling of the interministerial plan for “mobilisation and action on violence against children” by Laurence Rossignol, Minister for Families, Children and Women’s Rights.
- Press releases - 01.03.2017
Sickle cell disease : remission of disease symptoms in the world’s first patient treated using gene therapy
A team led by Prof. Marina Cavazzana, working at Necker Hospital for Sick Children, AP-HP, and the Imagine Institute (AP-HP/Inserm/Paris Descartes University) performed gene therapy on a 13-year-old patient with severe sickle cell anaemia in October 2014 as part of a phase I/II clinical trial. Conducted in collaboration with Prof. Philippe Leboulch (CEA/Faculties of Medicine at Paris-Sud and Harvard Universities), who developed the vector used, and supervised the preclinical studies, this innovative treatment provided complete remission from the clinical signs of the disease, and the correction of biological signs. Results (15-month follow up after transplantation) are published in the New England Journal of Medicine on 2 March 2017, and confirm the efficacy of this new therapy of the future.
- What's on? - 01.03.2017
1 March 2017: A plan for action on violence against children
Wednesday 1 March 2017 will see the unveiling of the interministerial plan for “mobilisation and action on violence against children” by Laurence Rossignol, Minister for Families, Children and Women’s Rights. Since early this year, the news has been marked by a series of infanticides in France. Although child abuse affects children from all backgrounds, official […]
- Press releases - 23.02.2017
Multiple sclerosis : Mission Regeneration !
Why does multiple sclerosis progress more rapidly in some patients than others? Why do some patients with MS manage to regenerate their myelin, while others do not? Inserm researchers at Unit 1127, “Brain and Spine Institute” (Inserm/CNRS/UPMC) have demonstrated that lymphocytes play a major role in the remyelination process, and that they could possibly be exploited to develop new myelin regeneration strategies.
- Press releases - 22.02.2017
28 February 2017: International Rare Disease Day
The 28 February 2017 marks the 10th edition of World Rare Disease Day, with the slogan “Join us in making the voice of rare diseases heard.” While there are 7,000 known rare diseases, 80% of them genetic in origin, new rare diseases are regularly discovered.
- What's on? - 22.02.2017
28 February 2017: International Rare Disease Day
© rarediseaseday.org The 28 February 2017 marks the 10th edition of World Rare Disease Day, with the slogan “Join us in making the voice of rare diseases heard.” While there are 7,000 known rare diseases, 80% of them genetic in origin, new rare diseases are regularly discovered. According to the definition used in Europe, a disease […]
- Press releases - 21.02.2017
Epidemics: urgent need for action
Inserm and the Coalition for Epidemic Preparedness Innovations (CEPI) are holding a large conference entitled “Vaccines Against Emerging Infections – a Global Insurance” on 21 and 22 February 2017. It is especially aimed at emphasising the urgent need for action and the potential for developing vaccines in the area of world epidemic crises. François Hollande, President of France, attended this conference today, along with Yves Levy, Chairman and CEO of Inserm, underscoring the major commitment of French research in this area.